Oncologists differ widely on offering cancer gene testing, study finds
3/26/2014
Many cancer researchers believe that cutting-edge advances in genomics will pave the way for personalized or "precision" cancer medicine for all patients in the near future.
Video glasses distract patients during procedures, keep them calm
3/26/2014
Music may soothe the soul, but it takes video to calm a patient undergoing medical treatment, notes a study in which individuals watched television shows or movies through special video glasses while having a biopsy or other minimally invasive treatment. The research is being presented at the Society of Interventional Radiology's 39th Annual Scientific Meeting.
Study identifies path to safer drugs for heart disease, cancer
3/26/2014
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging from heart attacks to cancer metastasis.
A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain, according to research being presented at the Society of Interventional Radiology's 39th Annual Scientific Meeting.
Scientists find genetic cause of a rare, aggressive ovarian cancer
3/25/2014
An international team of scientists has achieved a breakthrough by finding the genetic cause of a very rare and aggressive type of ovarian cancer that most often strikes girls and young women.The study, led by Translational Genomics Research Institute (TGen) a non-profit organization based in Phoenix, AZ, is published in the journal Nature Genetics.
Castle Biosciences Inc. has announced study results showing its gene expression profile (GEP) test (DecisionDx-Melanoma) can identify primary cutaneous (skin) melanoma tumors that are likely to metastasize in patients who had a negative sentinel lymph node biopsy.
Patients susceptible to leukemia treatment aftermaths identified
3/25/2014
The National Institute of Pediatrics (INP) in Mexico, conducted a study on genetic markers to identify children with acute leukemia, who may suffer side effects from the medications used to treat this type of cancer.
What keeps tumor cells in place
3/25/2014
Researchers at the University of Freiburg have found switches that colorectal cancer cells use to migrate away from the primary tumor site and to invade neighboring tissue. This migration is the first step in metastasis, the process by which the cancer forms secondary tumors in other organs. Prof. Dr.
Cancer Research UK launches trial to fight cancer caused by a common virus
3/25/2014
Cancer Research UK's Drug Development Office (DDO) has launched a trial of a vaccine to treat some forms of cancer caused by a common virus known as the Epstein Barr Virus (EBV).The trial is being presented today (Tuesday 25 March) at a conference to mark 50 years since Cancer Research UK first discovered the link between the EBV virus and cancer*.
Predicting prostate cancer survival by measuring circulating tumor cells
3/25/2014
New research by USC Norris Comprehensive Cancer Center scientists demonstrates that measuring circulating tumor cells (CTCs) - the cells that spread cancer through the body - may be a better predictor of patient survival than the prostate specific antigen (PSA).The research was published in the Journal of Clinical Oncology by a team led by Amir Goldkorn, M.D.